Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 14

1.

Identification of the source of elevated hepatocyte growth factor levels in multiple myeloma patients.

Rampa C, Tian E, Våtsveen TK, Buene G, Slørdahl TS, Børset M, Waage A, Sundan A.

Biomark Res. 2014 Apr 9;2(1):8. doi: 10.1186/2050-7771-2-8.

PMID:
24716444
[PubMed]
Free PMC Article
2.

Bone morphogenetic protein-9 suppresses growth of myeloma cells by signaling through ALK2 but is inhibited by endoglin.

Olsen OE, Wader KF, Misund K, Våtsveen TK, Rø TB, Mylin AK, Turesson I, Størdal BF, Moen SH, Standal T, Waage A, Sundan A, Holien T.

Blood Cancer J. 2014 Mar 21;4:e196. doi: 10.1038/bcj.2014.16.

PMID:
24658374
[PubMed]
Free PMC Article
3.

Oncogenic roles of PRL-3 in FLT3-ITD induced acute myeloid leukaemia.

Park JE, Yuen HF, Zhou JB, Al-Aidaroos AQ, Guo K, Valk PJ, Zhang SD, Chng WJ, Hong CW, Mills K, Zeng Q.

EMBO Mol Med. 2013 Sep;5(9):1351-66. doi: 10.1002/emmm.201202183. Epub 2013 Aug 8.

PMID:
23929599
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Generation of conditional knockout alleles for PRL-3.

Yan H, Kong D, Ge X, Gao X, Han X.

J Biomed Res. 2011 Nov;25(6):438-43. doi: 10.1016/S1674-8301(11)60058-4.

PMID:
23554722
[PubMed]
Free PMC Article
5.

B cell depletion in immune thrombocytopenia reveals splenic long-lived plasma cells.

Mahévas M, Patin P, Huetz F, Descatoire M, Cagnard N, Bole-Feysot C, Le Gallou S, Khellaf M, Fain O, Boutboul D, Galicier L, Ebbo M, Lambotte O, Hamidou M, Bierling P, Godeau B, Michel M, Weill JC, Reynaud CA.

J Clin Invest. 2013 Jan 2;123(1):432-42. doi: 10.1172/JCI65689. Epub 2012 Dec 17.

PMID:
23241960
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

The pro-metastasis tyrosine phosphatase, PRL-3 (PTP4A3), is a novel mediator of oncogenic function of BCR-ABL in human chronic myeloid leukemia.

Zhou J, Cheong LL, Liu SC, Chong PS, Mahara S, Bi C, Ong KO, Zeng Q, Chng WJ.

Mol Cancer. 2012 Sep 21;11:72. doi: 10.1186/1476-4598-11-72.

PMID:
22995644
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

miR-21, miR-17 and miR-19a induced by phosphatase of regenerating liver-3 promote the proliferation and metastasis of colon cancer.

Zhang J, Xiao Z, Lai D, Sun J, He C, Chu Z, Ye H, Chen S, Wang J.

Br J Cancer. 2012 Jul 10;107(2):352-9. doi: 10.1038/bjc.2012.251. Epub 2012 Jun 7.

PMID:
22677902
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

VEGF promotes the transcription of the human PRL-3 gene in HUVEC through transcription factor MEF2C.

Xu J, Cao S, Wang L, Xu R, Chen G, Xu Q.

PLoS One. 2011;6(11):e27165. doi: 10.1371/journal.pone.0027165. Epub 2011 Nov 2.

PMID:
22073279
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Retroviral integration mutagenesis in mice and comparative analysis in human AML identify reduced PTP4A3 expression as a prognostic indicator.

Beekman R, Valkhof M, Erkeland SJ, Taskesen E, Rockova V, Peeters JK, Valk PJ, Löwenberg B, Touw IP.

PLoS One. 2011;6(10):e26537. doi: 10.1371/journal.pone.0026537. Epub 2011 Oct 20.

PMID:
22028901
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

PRL-3, a metastasis associated tyrosine phosphatase, is involved in FLT3-ITD signaling and implicated in anti-AML therapy.

Zhou J, Bi C, Chng WJ, Cheong LL, Liu SC, Mahara S, Tay KG, Zeng Q, Li J, Guo K, Tan CP, Yu H, Albert DH, Chen CS.

PLoS One. 2011 May 12;6(5):e19798. doi: 10.1371/journal.pone.0019798.

PMID:
21589872
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Therapeutic potential of PRL-3 targeting and clinical significance of PRL-3 genomic amplification in gastric cancer.

Ooki A, Yamashita K, Kikuchi S, Sakuramoto S, Katada N, Waraya M, Kawamata H, Nishimiya H, Nakamura K, Watanabe M.

BMC Cancer. 2011 Apr 6;11:122. doi: 10.1186/1471-2407-11-122.

PMID:
21466710
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Targeting protein tyrosine phosphatases for anticancer drug discovery.

Scott LM, Lawrence HR, Sebti SM, Lawrence NJ, Wu J.

Curr Pharm Des. 2010 Jun;16(16):1843-62. Review.

PMID:
20337577
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

PRL-3 promotes the motility, invasion, and metastasis of LoVo colon cancer cells through PRL-3-integrin beta1-ERK1/2 and-MMP2 signaling.

Peng L, Xing X, Li W, Qu L, Meng L, Lian S, Jiang B, Wu J, Shou C.

Mol Cancer. 2009 Nov 24;8:110. doi: 10.1186/1476-4598-8-110.

PMID:
19930715
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

High expression of BCL3 in human myeloma cells is associated with increased proliferation and inferior prognosis.

Brenne AT, Fagerli UM, Shaughnessy JD Jr, Våtsveen TK, Rø TB, Hella H, Zhan F, Barlogie B, Sundan A, Børset M, Waage A.

Eur J Haematol. 2009 May;82(5):354-63. doi: 10.1111/j.1600-0609.2009.01225.x. Epub 2009 Jan 13.

PMID:
19191868
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk